MedTrace Logo

Virtual Reality Behavioral Activation: An Intervention for Major Depressive Disorder

NCT04268316 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-06-02

Study results available
· View outcomes & findings →

Summary

The primary purpose of this study is to test the safety and feasibility of virtual reality (VR) technology in the use of behavioral activation (BA) as a treatment for major depressive disorder (MDD). The secondary purpose of this study is to examine whether any evidence of clinical efficacy exists for VR delivered BA.

Conditions

Interventions

DEVICE

Virtual Reality Behavioral Activation

Participants will choose four "activities" to complete in virtual reality over the course of the week. These activities are video 360 and range from viewing animals, to viewing nature scenes, to traveling to a different location in the world, to viewing adrenaline-pumping activities.

BEHAVIORAL

Behavioral Activation in real-life

Participants will choose four pleasurable and/or mastery activities to complete over the course of the week in real life.

Sponsors & Collaborators

Principal Investigators

  • Kim Bullock, MD · Stanford University

  • Margot Paul, MS · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-18
Primary Completion
2021-01-15
Completion
2021-01-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04268316 on ClinicalTrials.gov